Vimarsana
Biggest News Aggregation in the World

Page 3 - Amount Centre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amount Centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amount Centre Today - Breaking & Trending Today

Long COVID: Joe Biden orders research push on pandemic's persistent strain - Vimarsana News

Long COVID: Joe Biden orders research push on pandemic's persistent strain

Long-COVID patients in the US could one day be entitled to the protection of federal laws that prohibit discrimination based on health conditions.

Source: smh.com.au
USD 209.07 Mn growth in Gender Reassignment Surgery Market 2021-2025 | Driven by Increase in the Number of People Opting for Sex Change Surgeries - Vimarsana News

USD 209.07 Mn growth in Gender Reassignment Surgery Market 2021-2025 | Driven by Increase in the Number of People Opting for Sex Change Surgeries

/PRNewswire/ -- The gender reassignment surgery market size is set to increase by USD 209.07 million, accelerating at over 8% from 2020 to 2025, according to...

Some Doctors Say They Won't Give Their Patients a Contentious New Alzheimer's Drug - Vimarsana News

Some Doctors Say They Won't Give Their Patients a Contentious New Alzheimer's Drug

Filed to:aducanumab alzheimers diseasebiogenclinical trialfederal assistance in the united statesfood and drug administrationhealth medical pharmahealthcare reform in the united statesjanet woodcockkaiser family foundationkatie porterlife sciencesmedicaidmedicarepresidency of lyndon b johnsonsam gandythe centers for medicare and medicaid services Photo: Matthew Simmons, Getty Images Parts of the medical world are continuing to rebel against Aduhelm, the controversial treatment developed by Biogen and recently approved for Alzheimer’s disease by the U.S. Food and Drug Administration. This we...